Skip to main content
SpringerLink
Log in

Changes in clinical trial length

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Clinical trial characteristics.
Figure 2: Changes in clinical trial length.

Author information

Authors and Affiliations

  1. UQ Business School, The University of Queensland, St Lucia, 4072, Queensland, Australia

    Lisette Pregelj, Martie-Louise Verreynne & Damian Hine

Authors
  1. Lisette Pregelj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martie-Louise Verreynne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Damian Hine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Damian Hine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (box)

Data, methods and additional analyses (PDF 1600 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pregelj, L., Verreynne, ML. & Hine, D. Changes in clinical trial length. Nat Rev Drug Discov 14, 307–308 (2015). https://doi.org/10.1038/nrd4611

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4611

  • Springer Nature Limited

This article is cited by

Search

Navigation